LEGEND-HTN found benefit for patients treated with thiazide or thiazide-like diuretics compared to angiotensin-converting enzyme (ACE) inhibitors in terms of three main outcomes of interest, i.e., acute myocardial infarction (MI), hospitalization with heart failure, and stroke. This evidence concerns the gene ACE and hypertensive disorder.